• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » 340 organizations ask Congress for telehealth to stay

340 organizations ask Congress for telehealth to stay

June 30, 2020 By Sean Whooley

Today, 340 companies signed a letter sent to Congress to urge leaders to make COVID-19-related telehealth flexibilities permanent.

Representing all 50 states, Washington, D.C., and Puerto Rico, the signees are seeking to stop the potential for telehealth flexibilities to disappear, should Congress fail to act before the COVID-19 public health emergency expires, according to a news release.

At the beginning of the pandemic, Congress waived statutory barriers to allow for expanded access to telehealth, offering federal agencies the flexibility to allow healthcare providers to deliver care virtually. The letter says that those flexibilities will immediately go away if Congress doesn’t act.

The 340 stakeholders who signed the letter urged Congress to remove obsolete restrictions on the location of the patient so care can be accessed at home, maintain and enhance Dept. of Health & Human Services (HHS) authority to determine appropriate providers for telehealth, ensure federally qualified health centers and rural clinics can furnish telehealth services and make permanent the HHS temporary waiver authority for future emergencies.

Some federal agencies can address some of the policies going forward, but the Centers for Medicare & Medicaid (CMS) does not have the authority to make changes to its reimbursement policy for telehealth, so it believes that Congress acting on the priorities listed would allow CMS to build on its experience gained during the pandemic and expand access to telehealth in a data-driven manner.

The organizations co-leading the effort include AdvaMed, the Alliance for Connected Care, the American Telemedicine Association, the eHealth Initiative, the Health Innovation Alliance and the Personal Connected Health Alliance.

“Too many patients are still going without care that is absolutely vital to their health and putting essential medical procedures on hold due to the pandemic or lack of access to care,” AdvaMed president & CEO Scott Whitaker said in the release. “Making recently expanded telehealth access permanent will improve patients’ ability to get care outside of doctors’ offices and other traditional health care settings and save and improve countless lives.”

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Legal News Tagged With: AdvaMed, Congressional, coronavirus, COVID-19, Telehealth, U.S. Department of Health and Human Services

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy